Corrigendum to "Systemic inflammation alters central 5-HT function as determined by pharmacological MRI" [Neuroimage 75 (2013) 177-186]

Corrigendum to "Systemic inflammation alters central 5-HT function as determined by pharmacological MRI" [Neuroimage 75 (2013) 177-186]

Dettagli Bibliografici
Autori principali:	Couch, Y, Martin, C, Howarth, C, Raley, J, Khrapitchev, A, Stratford, M, Sharp, T, Sibson, N, Anthony, D
Natura:	Journal article
Lingua:	English
Pubblicazione:	Academic Press Inc. 2014

Documenti analoghi

Systemic inflammation alters central 5-HT function as determined by pharmacological MRI (vol 75, pg 177, 2013)
di: Couch, Y, et al.
Pubblicazione: (2014)

Systemic inflammation alters central 5-HT function as determined by pharmacological MRI.
di: Couch, Y, et al.
Pubblicazione: (2013)

Systemic inflammation alters central 5-HT function as determined by pharmacological MRI.
di: Couch, Y, et al.
Pubblicazione: (2013)

Neurovascular and neuroimaging effects of the hallucinogenic serotonin receptor agonist psilocin in the rat brain.
di: Spain, A, et al.
Pubblicazione: (2015)

Pharmacological MRI in animal models: a useful tool for 5-HT research?
di: Martin, C, et al.
Pubblicazione: (2008)

A possible role for 5-HT2C receptors in postsynaptic feedback regulation of 5 HT neurones
di: Raley, J, et al.
Pubblicazione: (2006)

Evidence that increased 5-HT release evokes region-specific effects on blood-oxygenation level-dependent functional magnetic resonance imaging responses in the rat brain.
di: Preece, M, et al.
Pubblicazione: (2009)

In vivo evidence that 5-HT(2C) receptors inhibit 5-HT neuronal activity via a GABAergic mechanism.
di: Boothman, L, et al.
Pubblicazione: (2006)

Important messages in the 'post': recent discoveries in 5-HT neurone feedback control.
di: Sharp, T, et al.
Pubblicazione: (2007)

Mapping of anxiogenic neuronal profiles induced by the GABA inverse agonist FG-7142 and caffeine using pharmacological magnetic resonance imaging
di: Sekar, S, et al.
Pubblicazione: (2010)

Corrigendum: Developments in 177Lu-based radiopharmaceutical therapy and dosimetry
di: Siju C. George, et al.
Pubblicazione: (2024-04-01)

Region-specific effects of a tyrosine-free amino acid mixture on amphetamine-induced changes in BOLD fMRI signal in the rat brain.
di: Preece, M, et al.
Pubblicazione: (2007)

Further pharmacological characterization of 5-HT(2C) receptor agonist-induced inhibition of 5-HT neuronal activity in the dorsal raphe nucleus in vivo.
di: Quérée, P, et al.
Pubblicazione: (2009)

Pruning in poplar plantations by mechanized device Stihl HT-75
di: Danilović Milorad, et al.
Pubblicazione: (2009-01-01)

PHARMACOLOGICAL CHARACTERIZATION OF CENTRAL TACHYKININ-5-HT INTERACTIONS
di: Stoessl, A, et al.
Pubblicazione: (1988)

Pharmacological Approaches to Pain and Consciousness Using Functional Neuroimaging
di: Tracey, I, et al.
Pubblicazione: (2016)

Editorial: In vivo functional neuroimaging for pharmacology
di: Benjamin Vidal, et al.
Pubblicazione: (2023-09-01)

Neuroimaging of animal models of brain disease.
di: Lythgoe, M, et al.
Pubblicazione: (2003)

Combined optogenetic and pharmacological analysis of 5-HT control of cortical microcircuitry
di: So, C
Pubblicazione: (2023)

A Model of Post-Infection Fatigue Is Associated with Increased TNF and 5-HT2A Receptor Expression in Mice.
di: Yvonne Couch, et al.
Pubblicazione: (2015-01-01)

Effects of the 5-HT(4) receptor agonist RS67333 and paroxetine on hippocampal extracellular 5-HT levels.
di: Licht, C, et al.
Pubblicazione: (2010)

The effect of inflammation on the central 5-HT system in mood disorders
di: Couch, Y
Pubblicazione: (2012)

Evaluation of excitation function for 186W(d,2n)186Re reaction
di: Wang Jimin, et al.
Pubblicazione: (2017-01-01)

186:poster Poverty discrimination
di: Kasper Lippert-Rasmussen, et al.
Pubblicazione: (2022-04-01)

Preclinical study of a new 177Lu-labeled somatostatin receptor antagonist in HT-29 human colorectal cancer cells
di: Hossein Behnammanesh, et al.
Pubblicazione: (2020-07-01)

Corrigendum to “Determination of normative reference for the definition of sarcopenia among Filipinos” [Osteoporos. Sarcopenia 2 (2016) 186–190]
di: Michael L. Tee, et al.
Pubblicazione: (2016-12-01)

Evidence that 5-HT2 receptor agonist induced inhibtion of 5-HT cell firing is mediated by central and not peripheral 5-HT2 receptors
di: Boothman, L, et al.
Pubblicazione: (2003)

Comparison of MRI signatures in pattern I and II multiple sclerosis models.
di: Serres, S, et al.
Pubblicazione: (2009)

Expression of 5-HT receptors and the 5-HT transporter in rat brain after electroconvulsive shock.
di: Burnet, P, et al.
Pubblicazione: (1999)

CORRELATIONS AT LARGE SCALES AND THE ONSET OF TURBULENCE IN THE FAST SOLAR WIND (vol 778, pg 177, 2013)
di: Wicks, RT, et al.
Pubblicazione: (2014)

THE NUCLEAR MAGNETIC-MOMENT OF IR-186
di: Allsop, A, et al.
Pubblicazione: (1982)

5-HT and depression: is the glass half-full?
di: Sharp, T, et al.
Pubblicazione: (2011)

Fast scan cyclic voltammetry evidence that 5-HT transporter overexpression impairs the function of 5-HT nerve terminals
di: Jennings, K, et al.
Pubblicazione: (2008)

Improved Detection of Molecularly Targeted Iron Oxide Particles in Small Animals with High Resolution MRI
di: Kinchesh, P, et al.
Pubblicazione: (2019)

Simultaneous blockade of 5-HT1A/B receptors and 5-HT transporters results in acute increases in extracellular 5-HT in both rats and guinea pigs: in vivo characterization of the novel 5-HT1A/B receptor antagonist/5-HT transport inhibitor SB-649915-B.
di: Hughes, Z, et al.
Pubblicazione: (2007)

Control of amygdala circuits by 5-HT neurons via 5-HT and glutamate co-transmission
di: Sengupta, A, et al.
Pubblicazione: (2017)

Non-linear relationship between 5-HT transporter gene expression and frequency sensitivity of 5-HT signals.
di: Jennings, K, et al.
Pubblicazione: (2010)

Corrigendum: A single-institution experience with 177Lu RPT workflow improvements and qualifying the SPECT/CT imaging for dosimetry
di: Siju C. George, et al.
Pubblicazione: (2024-04-01)

Quantitative Bayesian model-based analysis of amide proton transfer MRI
di: Chappell, M, et al.
Pubblicazione: (2013)

Quantitative Bayesian model-based analysis of amide proton transfer MRI.
di: Chappell, M, et al.
Pubblicazione: (2013)